- News & Analysis
Page 831
Cancer spawns multiple battlegrounds
How are university spin-outs shaping the battle against cancer?
Oct 19, 2014Health engagement platform Welltok raises $25m
Welltok raised the cash in a series D round funded by Bessemer Venture Partners, bringing the total raised by the company to $70.8m.
Oct 17, 2014Intelligent Ultrasound raises $2m
IP Group and angel investors are investing in the Oxford spin-out.
Oct 17, 2014Auspherix partners with Domainex
UTS spin-out Auspherix is hoping the collaboration will lead to a clinical drug candidate.
Oct 17, 2014Rigontec raises $11.9m series A
Rigontec, which develops RNA-based immunotherapeutics for the treatment of cancer, has raised $11.9m in a series A round featuring High-Tech Gruenderfonds.
Oct 16, 2014Raze Therapeutics closes $24m series A
Cancer treatment developer Raze Therapeutics has secured $24m from a series A round that included Novartis and Astellas' corporate venturing arm, Astellas Venture Management.
Oct 16, 2014Bicycle Therapeutics speeds up for series B
Biotherapeutics company Bicycle Therapeutics has raised $32m in a series B round featuring pharmaceutical companies GlaxoSmithKline, Novartis and Astellas.
Oct 16, 2014Australia announces $350m policy
Research is set to get a boost as Australian government outlines new policy.
Oct 16, 2014Australian National University sets up joint venture
NuCoria is being set up through a collaboration with Seeing Machines.
Oct 16, 2014About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
© 2026 Mawsonia Ltd. All rights reserved.test regLogin